Perrakis Aristotelis, Müller Volker, Oeckl Karin, Adamietz Boris, Demir Resit, Hohenberger Werner, Yedibela Sueleyman
Department of Surgery, University of Erlangen-Nuremberg, Erlangen, Germany.
Am Surg. 2012 Jan;78(1):80-5.
The management of hepatocellular adenoma (HA) is dependent on several parameters, which are influencing the decision for further management. The aim of this study was to evaluate the clinical presentation, indications, and long-term outcome of surgical treatment in a single-institution analysis. Forty-nine patients underwent elective hepatectomy for HA between 1990 and 2007. Analysis parameters included demographic data, lesion number and size, diagnostic method, mode of surgery, and postoperative outcome. Mean follow-up was 108 months. Thirty-six patients underwent hormone therapy and four patients had a history of cancer before surgical treatment. The mean tumor diameter was 9.8 cm. Mild or moderate postoperative complications were recorded in 16 patients. There was no perioperative mortality. Symptoms were relieved in 95 per cent of the patients. Intratumoral hemorrhage was detected in 21 specimens (43%); malignant transformation was detected in zero specimens. Among patients with HA with clinical symptoms, tumor diameter greater than 5 cm and in male patients the indication for surgery should be given because of the high risk of tumor-related complications. Elective liver resection for HA is a safe procedure and results in a good long-term outcome.
肝细胞腺瘤(HA)的管理取决于几个参数,这些参数会影响进一步管理的决策。本研究的目的是在单机构分析中评估手术治疗的临床表现、适应证和长期结果。1990年至2007年间,49例患者因HA接受了择期肝切除术。分析参数包括人口统计学数据、病变数量和大小、诊断方法、手术方式和术后结果。平均随访时间为108个月。36例患者接受了激素治疗,4例患者在手术治疗前有癌症病史。肿瘤平均直径为9.8 cm。16例患者记录有轻度或中度术后并发症。无围手术期死亡。95%的患者症状得到缓解。21份标本(43%)检测到瘤内出血;0份标本检测到恶性转化。对于有临床症状、肿瘤直径大于5 cm的HA患者以及男性患者,由于肿瘤相关并发症风险高,应给予手术适应证。HA的择期肝切除术是一种安全的手术,长期效果良好。